TSX:JWEL • CA4707481046
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for JAMIESON WELLNESS INC (JWEL.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-07 | Canaccord Capital | Downgrade | |
| 2022-11-04 | RBC Royalbank | Downgrade | Outperform |
| 2022-11-04 | TD Research | Maintains | Buy |
| 2022-11-04 | CIBC Capital Markets | Downgrade | Outperform |
| 2022-11-04 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-10-31 | CIBC Capital Markets | Maintains | Outperform |
| 2022-08-29 | TD Research | Upgrade | Action List Buy |
| 2022-08-05 | RBC Royalbank | Downgrade | Outperform |
| 2022-08-05 | BMO Financial | Maintains | Outperform |
| 2022-08-05 | CIBC Capital Markets | Upgrade | Outperform |
| 2022-08-05 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-06-03 | RBC Royalbank | Upgrade | Outperform |
| 2022-06-02 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-06-02 | TD Research | Upgrade | Buy |
| 2022-06-02 | CIBC Capital Markets | Upgrade | Outperform |
| 2022-06-02 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-06-02 | Eight Capital | Upgrade | Buy |
| 2022-05-09 | BMO Financial | Upgrade | Market Perform |
| 2022-05-06 | CIBC Capital Markets | Maintains | Outperform |
| 2022-05-06 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-04-28 | CIBC Capital Markets | Maintains | Outperform |
| 2022-02-25 | RBC Royalbank | Downgrade | Outperform |
| 2022-02-25 | CIBC Capital Markets | Downgrade | Outperform |
| 2022-02-25 | Scotiabank Capital | Downgrade | Sector Perform |
| 2022-01-21 | TD Research | Upgrade | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 676.172M 23.53% | 733.78M 8.52% | 822.056M 12.03% | 934.18M 13.64% | 1.024B 9.61% | 1.044B 1.95% | N/A | N/A | |
| EBITDA YoY % growth | 137.68M 16.62% | 130.162M -5.46% | 156.57M 20.29% | 183.09M 16.94% | 204.02M 11.43% | 210.02M 2.94% | 233.17M 11.02% | 245.44M 5.26% | |
| EBIT YoY % growth | 117.357M 16.41% | 111.63M -4.88% | 136.913M 22.65% | 146.88M 7.28% | 162.79M 10.83% | 175.95M 8.08% | 212.88M 20.99% | 224.81M 5.60% | |
| Operating Margin | 17.36% | 15.21% | 16.65% | 15.72% | 15.90% | 16.85% | N/A | N/A | |
| EPS YoY % growth | 1.55 0.65% | 1.61 3.87% | 1.85 14.91% | 2.18 17.90% | 2.54 16.45% | 2.64 4.02% | N/A | N/A |
All data in CAD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.14 -2.37% | 0.44 10.67% | 0.52 27.38% | 1.05 17.19% | 0.17 26.87% | 0.52 17.51% | 0.58 11.33% | 1.21 15.09% |
| Revenue Q2Q % growth | 165.48M 13.37% | 227.93M 14.47% | 225.83M 13.30% | 315.82M 13.74% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 21.374M 35.88% | 40.65M 7.61% | 43.825M -3.86% | 75.69M -11.29% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 12.444M 13.38% | 30.09M 7.30% | 35.19M 13.60% | 69.156M 5.31% | N/A | N/A | N/A | N/A |
All data in CAD
13 analysts have analysed JWEL.CA and the average price target is 45.99 CAD. This implies a price increase of 35.57% is expected in the next year compared to the current price of 33.92.
JAMIESON WELLNESS INC (JWEL.CA) will report earnings on 2026-04-30.
The consensus EPS estimate for the next earnings of JAMIESON WELLNESS INC (JWEL.CA) is 0.14 CAD and the consensus revenue estimate is 165.48M CAD.
The expected long term growth rate for JAMIESON WELLNESS INC (JWEL.CA) is 7.62%.